Literature DB >> 23504339

Comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions".

Sibylle Neuhoff, Geoff T Tucker.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23504339     DOI： 10.1007/s11095-013-0988-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  15 in total

1.  Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034.

Authors:  Jasminder Sahi; Michael W Sinz; Scott Campbell; Rouchelle Mireles; Xianxian Zheng; Kelly A Rose; Shamsi Raeissi; Muhammed F Hashim; Yuyang Ye; Sonia M de Morais; Christopher Black; Meera Tugnait; Laurence H Keller
Journal:  Chem Biol Interact       Date:  2005-12-13       Impact factor: 5.192

2.  Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Authors:  J M Fernandez-Real; M Vayreda; C Richart; C Gutierrez; M Broch; J Vendrell; W Ricart
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

3.  Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.

Authors:  Yoshihisa Shitara; Kumiko Takeuchi; Yoshiko Nagamatsu; Satomi Wada; Yuichi Sugiyama; Toshiharu Horie
Journal:  Drug Metab Pharmacokinet       Date:  2012-01-13       Impact factor: 3.614

4.  Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.

Authors:  Emilie Jigorel; Marc Le Vee; Claire Boursier-Neyret; Yannick Parmentier; Olivier Fardel
Journal:  Drug Metab Dispos       Date:  2006-07-12       Impact factor: 3.922

5.  Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.

Authors:  Olaf Schaefer; Sumio Ohtsuki; Hirotaka Kawakami; Tae Inoue; Stephanie Liehner; Asami Saito; Atsushi Sakamoto; Naoki Ishiguro; Takehisa Matsumaru; Tetsuya Terasaki; Thomas Ebner
Journal:  Drug Metab Dispos       Date:  2011-10-06       Impact factor: 3.922

6.  Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin.

Authors:  Rune Amundsen; Hege Christensen; Behnaz Zabihyan; Anders Asberg
Journal:  Drug Metab Dispos       Date:  2010-06-02       Impact factor: 3.922

7.  Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6.

Authors:  Marc Le Vee; Valérie Lecureur; Bruno Stieger; Olivier Fardel
Journal:  Drug Metab Dispos       Date:  2008-12-15       Impact factor: 3.922

8.  CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects.

Authors:  Thomas Giessmann; Christiane Modess; Ute Hecker; Michael Zschiesche; Peter Dazert; Christiane Kunert-Keil; Rolf Warzok; Georg Engel; Werner Weitschies; Ingolf Cascorbi; Heyo K Kroemer; Werner Siegmund
Journal:  Clin Pharmacol Ther       Date:  2004-03       Impact factor: 6.875

9.  Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human.

Authors:  Na Li; Yiqun Zhang; Fengmei Hua; Yurong Lai
Journal:  Drug Metab Dispos       Date:  2008-10-02       Impact factor: 3.922

10.  Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes.

Authors:  Na Li; Yi-An Bi; David B Duignan; Yurong Lai
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.